← Leaderboards
Pauline Byakika-Kibwika
Infectious Diseases Institute
$372,883
Attributed
$372,883
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $174.2K · FY2019–21$200K$150K$100K$50K$0
'19
'20
'21
Funding mix
By agency
NIH$372,883 · 1
By mechanism
G11$372,883 · 1
Top collaborators
No co-investigators on record.
Most similar at Infectious Diseases Institute
Same institution · by research overlap
- David Bisagaya Meya$12,205,470
- Stephen Okoboi$329,717
- Fred Wabwire-Mangen$2,120,567
Others in their field
Other Emerging Leaders on “Acquired Immunodeficiency Syndrome”
- Kimberly Smith · Ppd Development Lp$122,008,792
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,132,816
- Bambra Strokes · Ppd Development Lp$65,000,267
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$44,034,909
Research focus
Acquired Immunodeficiency SyndromeAdministratorAfrica South Of The SaharaAreaAutomobile DrivingBaseCommittee MembersCommunicable DiseasesComorbidityComplexComputer SoftwareCountryDesignDisciplineEducational CurriculumE-LearningElementsEnsureEpidemicEthical IssuesEthical ReviewEthicsFeedbackAccreditation
Grant awards (4)
Towards eliminating HIV in Uganda by 2030; Preparing Ethical Review Committees to support this agenda$99,290
G11 · FY2021 · TW · contact PI
Towards eliminating HIV in Uganda by 2030; Preparing Ethical Review Committees to support this agenda$99,246
G11 · FY2020 · TW · contact PI
Towards eliminating HIV in Uganda by 2030; Preparing Ethical Review Committees to support this agenda$75,000
G11 · FY2020 · TW · contact PI
Towards eliminating HIV in Uganda by 2030; Preparing Ethical Review Committees to support this agenda$99,347
G11 · FY2019 · TW · contact PI